May 29, 2018 7:00 am EDT Capricor Therapeutics to Present at the 2018 BIO International Convention in Boston
May 10, 2018 4:00 pm EDT Capricor Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update
May 04, 2018 8:00 am EDT Capricor Therapeutics to Present First Quarter 2018 Financial Results and Corporate Update on May 10
May 03, 2018 7:00 am EDT Capricor to Present on Exosomes at the Plenary Session of the International Society for Cellular Therapy in Montreal
Apr 30, 2018 7:00 am EDT Capricor Announces Initiation of HOPE-2 Clinical Trial of CAP-1002 for Duchenne Muscular Dystrophy
Apr 19, 2018 7:00 am EDT Capricor Announces New Pre-Clinical Study Finds Repeat Doses of CAP-1002 Lead to Enhanced Exercise Capacity in Duchenne Muscular Dystrophy Disease Model
Apr 12, 2018 7:00 am EDT Capricor to Provide Presentation at the Alliance for Regenerative Medicine’s Investor Day
Mar 21, 2018 7:00 am EDT Capricor Therapeutics to Present at Upcoming Oppenheimer and Needham Healthcare Conferences
Mar 14, 2018 4:00 pm EDT Capricor Presents Fourth Quarter and Full Year 2017 Financial Results and Corporate Update